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Objective: The purpose of this article is to describe the application of hysteroscopy in different cases of
gestational trophoblastic disease.
Materials and methods: Three patients who presented with gestational trophoblastic disease were
managed with hysteroscopy. The ﬁrst case was a hydatidiform mole that underwent transcervical
resectionwith endometrial curettage. The second case had a history of suction curettage for hydatidiform
mole. She underwent transcervical resection for retained products of conception. The third case had a
history of suction curettage for hydatidiform mole. In contrast with the second case, the patient had
rising b human chorionic gonadotropin (b-HCG) values prior to transcervical resection and eventually
underwent chemotherapy in the form of methotrexate.
Results: The surgical procedure was uneventful in all three patients. All three operations were performed
in <15 minutes. The blood loss was <50 mL, and there was no ﬂuid deﬁcit.
Conclusion: Different cases of gestational trophoblastic disease can bemanaged effectively by hysteroscopy.
Copyright © 2015, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Although hysteroscopy has been a popular topic for research,
the concept of using this method for gestational trophoblastic
disease is relatively new. With the advancements made in hyster-
oscopy, applying this method to offer better treatment options for
gestational trophoblastic disease is now a possibility. We present
three cases of gestational trophoblastic diseasedone hydatidiform





A 35-year-old woman, G3P0, presented with 7 weeks amen-
orrhea and vaginal spotting. Ultrasonography showed ant relevant to this article was
and Gynecology, Chang Gung
g Gung University College of
Taiwan.
uang).
for Gynecologic Endoscopy and Minimendometrial cavity with a single gestational sac. Within the
gestational sac was an embryonic pole with no cardiac activity.
Occupying the gestational sac at its peripheral pole was an irreg-
ularly shaped complex mass (Figure 1). Baseline serum b human
chorionic gonadotropin (b-HCG) was 111,582 mIU/mL. Chest x-ray
was negative. The patient underwent hysteroscopy with endo-
metrial curettage.
Case 2
A 46-year-old woman, G2P2, underwent suction curettage for
complete hydatidifommole. Chest x-ray was negative. Her initial b-
HCG was 8856 mIU/mL. She had regular follow up with decreasing
b-HCG values. Two months after the operation, she complained of
vaginal spotting. Ultrasonography showed a slightly thickened
endometrium with a hyperechoic mass suggestive of retained
trophoblastic tissues. Ofﬁce hysteroscopy conﬁrmed the retained
trophoblastic tissue at the right cornu (Figure 2). b-HCG at this time
was 187.7 mIU/mL. She underwent transcervical resection of the
mass at the right cornu.
Case 3
A 33-year-old woman, G1P0, underwent suction curettage for
hydatidiform mole. She remained asymptomatic and continued to
have weekly b-HCG determinations. One week postcurettage, herally Invasive Therapy. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1. Ultrasound image showing an endometrial cavity with a single gestational
sac. Within the gestational sac is as an embryonic pole with absent cardiac activity.
Occupying the gestational sac at its peripheral pole is an irregularly shaped complex
mass (indicated by green arrow). NO FHB ¼ no fetal heartbeat.
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curettage to 5592 mIU/mL prompted further investigation. Meta-
static workup was negative. On ultrasound, there was an irregular
heterogenous mass occupying the endometrial cavity with dense
vascularity and no note of any myometrial invasion. She underwent
transcervical resection of the mass.Surgical method
After administration of intravenous general anesthesia with
oxygen supply by a mask, the patients were placed in the Trende-
lenburg position and supported in stirrups. Hysteroscopy was
performed using a 26F continuous ﬂow resectoscope ﬁtted with a
90 wire loop (Karl Storz GmbH & Co., Tuttlingen, Germany).
Distilled water was used for distention and irrigation. In the ﬁrst
case, intraoperative hysteroscopic ﬁndings showed a 10-week sizedFigure 2. Hysteroscopic image of retained trophoblastic tissues at the right cornu of
the uterus.uterus containing grape-like vesicles (Figure 3). Gentle curettage
was performed using a metal curette and the hysteroscope was
reinserted to check the uterine cavity for any residual tissues.
Electrodissection was not used, however, the wire was used as a
curette to remove any residual tissue noted after curettage. Fluid
balance was recorded and the specimen was sent to pathology for
evaluation. The second and third case involved the same surgical
method except that the metal curette was not used.
Results
The surgical procedure was uneventful in all three patients. All
three operations were performed in <15 minutes. The blood loss
was <50 mL and there was no ﬂuid deﬁcit. For the ﬁrst case, the
patient had an uneventful postoperative course. Histopathologic
diagnosis was compatible with partial hydatidiform mole. Weekly
serum b-HCG determinations performed after the operation
showed decreasing levels at 183.1 mIU/mL, 22.7 mIU/mL, and
2.7 mIU/mL, respectively. The succeeding determinations remained
within normal limits. For the second case, the histopathological
result was compatible with retained trophoblastic tissue. b-HCG 1
week after the operation was 4 mIU/mL. The succeeding de-
terminations remained within normal limits. For the third case,
histopathologic evaluation was consistent with retained hydatidi-
form mole. The patient's b-HCG decreased to 345.2 mIU/mL, how-
ever, ultrasound showed a thickened endometrium at 1.42 cm. She
underwent another transcervical resection but histopathology
revealed only necrotic tissues. She underwent chemotherapy in the
form of methotrexate, and b-HCG decreased to <2mIU/mL after the
third dose. She received the last two doses of chemotherapy as
clean-up courses and her b-HCG levels remained at normal levels
thereafter.
Discussion
Hydatidiform mole is an abnormal pregnancy characterized by
trophoblastic proliferation of both the cytotrophoblast and syncy-
tiotrophoblast.1 It occurs in two out of 1000 women of reproductive
age.1 Early diagnosis of hydatidiform mole using ultrasound has
changed the presentation of hydatidiform mole.1e3 In this case, the
ultrasound picture did not show the classic snowstorm appearance
found in molar pregnancy because it was seen at a very early stage.
Molar pregnancy ultrasound ﬁndings in the ﬁrst trimester are
nonspeciﬁc because the villi are not hydropic.3 The elevated serum
levels of b-HCG increased the suspicion of gestational trophoblasticFigure 3. Hysteroscopic image of the grape-like pattern characteristic of hydatidiform
mole.
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ﬁrming the diagnosis of hydatidiform mole. Direct visualization of
the uterine cavity after curettage also ensures that all the tropho-
blastic tissues have been removed. The gold standard for evacua-
tion of hydatidiform mole is suction curettage.2,4 Very few reports
have utilized hysteroscopy in diagnosing molar pregnancy. Yanez
et al5 reported a 31-year-old patient with elevated b-HCG and
inconclusive ultrasound ﬁndings that conﬁrmed the diagnosis of
hydatidiformmole by hysteroscopy. Similarly Di Spiezio Sardo et al6
describes a 51-year-old woman with abnormal bleeding who was
diagnosed with hydatidiform mole on ofﬁce hysteroscopy.
The second case involves a patient with retained placental tis-
sues after suction curettage for hydatidifrom mole. Perez-Medina
et al7 describes the hysteroscopic appearance of retained tropho-
blastic tissue which appeared as a whitish, well-deﬁned cotton like
structure that protrudes into the endometrial cavity and was sur-
rounded by normal endometrial tissue. This description is very
accurate and was clearly seen in the second case (Figure 2). One
report by Wilczak et al8 describes a patient who exhibited persis-
tently elevated b-HCG values after suction curettage for hydatidi-
formmole. A polypoid lesionwas resected during hysteroscopy and
subsequently brought the b-HCG values to normal levels. By
contrast, the second case had decreasing b-HCG values despite
having a visible mass at the right cornu. In time, the mass may have
resolved on its own, given that there was no plateauing in the
decline in b-HCG values. It is likely that transcervical resection of
themass aided in bringing down the b-HCG values to normal levels.
Transcervical resection is an alternative procedure to the traditional
dilatation and evacuation for retained trophoblastic tissues.9 The
value of directly visualizing the endometrial cavity in cases such as
these cannot be over emphasized. Because the mass was located at
the right cornu, and it only occupied a small area of the uterine
cavity, targeted removal of the tissuewas themost useful approach.
Visualization of the target area will help prevent inﬂammation and
scarring which could occur if a blind procedure was performed.10
Further inﬂammation of the endometrium was avoided by using
thewire of the resectoscope as a curette instead of electroagulation.
Using electrical equipment is believed to cause surgical trauma and
inﬂammation to the endometrium that can lead to adhesions in the
future.7
The third case is more complex. The authors believe that the rise
in the b-HCG is indicative of a Stage I gestational trophoblastic
neoplasia. Suzuki et al11 reported 21 patients suspected of gesta-
tional trophoblastic neoplasia who underwent hysteroscopy. Nine
of the 21 patients had conﬁrmed histopathologic ﬁndings of
gestational trophoblastic neoplasia. Gestational trophoblastic
neoplasia does not require a tissue diagnosis before initiating
treatment. Traditionally, chemotherapy should have been the ﬁrst
option. Surgery for gestational trophoblastic neoplasia is reserved
for resistant cases and if there are complications such as uncon-
trolled bleeding or uterine perforation.2 It must be kept in mind
that resecting such tumors can lead to unfavorable outcomes
because the tumors are highly vascular and may have myometrial
invasion. However, it can be presumed that the procedure helped in
decreasing tumor burden thereby lowering the b-HCG that was
instrumental in decreasing the number of doses of chemotherapy.In patients with cancer, infusing a large amount of ﬂuid inside the
uterine cavity may cause tumor dissemination, which is a cause for
concern. Lee et al12 discussed the role of endoscopy in endometrial
cancer. In their paper, the authors noted that seeding of cancer cells
in the uterine cavity does not affect the prognosis of patients with
endometrial cancer who underwent hysteroscopy and does not
increase the spread of cancer.12 In retrospect, the authors believe
that the second transcervical resectionwas no longer necessary and
that the chemotherapy in the form of methotrexate was crucial in
bringing down the b-HCG to normal levels.Conclusion
The three cases presented highlight how hysteroscopy can be
applied to gestational trophoblastic disease. Using a hysteroscopic
approach can offer several advantages such as direct visualization
of the uterine cavity, removal of the mass without harming the
healthy endometrium, and collection of specimens for histopath-
ologic evaluation.13Acknowledgement
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